Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 10 articles:
HTML format



Single Articles


    January 2025
  1. LI P
    Risankizumab for Ulcerative Colitis.
    JAMA. 2025 Jan 22. doi: 10.1001/jama.2024.25640.
    PubMed    


  2. LOUIS E, Kalabic J, Loftus EV Jr
    Risankizumab for Ulcerative Colitis-Reply.
    JAMA. 2025 Jan 22. doi: 10.1001/jama.2024.25643.
    PubMed    


    October 2024
  3. VESTERGAARD MV, Nohr AK, Allin KH, Krarup H, et al
    HLA-DRB1*01:03 and Severe Ulcerative Colitis.
    JAMA. 2024 Oct 15:e2420429. doi: 10.1001/jama.2024.20429.
    PubMed    


    July 2024
  4. LOUIS E, Schreiber S, Panaccione R, Bossuyt P, et al
    Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
    JAMA. 2024 Jul 22:e2412414. doi: 10.1001/jama.2024.12414.
    PubMed     Abstract available


  5. KAPLAN GG
    Monoclonal Antibody Risankizumab for Ulcerative Colitis.
    JAMA. 2024 Jul 22. doi: 10.1001/jama.2024.8819.
    PubMed    


    February 2024
  6. VOELKER R
    What Is Ulcerative Colitis?
    JAMA. 2024 Feb 2. doi: 10.1001/jama.2023.23814.
    PubMed    


    November 2023
  7. SURAN M
    Highlights From Gastroenterology Week: New Crohn Disease Drug, Redefining Liver Disease, and More.
    JAMA. 2023 Nov 2. doi: 10.1001/jama.2023.19140.
    PubMed    


    September 2023
  8. GROS B, Kaplan GG
    Ulcerative Colitis in Adults: A Review.
    JAMA. 2023;330:951-965.
    PubMed     Abstract available


    March 2023
  9. HARRIS E
    Patients With Normal Gut Biopsy Still at Increased Risk of IBD.
    JAMA. 2023;329:875.
    PubMed    


  10. ZHANG S, Chen B, Wang B, Chen H, et al
    Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis: A Randomized Clinical Trial.
    JAMA. 2023;329:725-734.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.